These observations are in agreement with the results of the current study, whereby SJZ, LZ, and FZLZ suppressed liver inflammation due to NAFLD, as suggested by the decrease in IL-6, IL-12, iNOS, TNF-α, and IL-1β expression in liver tissues (Table 2 and Figure 4). The gene discussed is NOS2; the disease is metabolic dysfunction-associated steatotic liver disease.